Lung Cancer Surgery Market

Global Lung Cancer Surgery Market Size, Trends & Analysis - Forecasts to 2028 By Type (Thoracotomy, Minimally Invasive Surgeries), By Product (Surgical Devices, Monitoring Devices), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 20 2024 with the latest and most recent market numbers

Global Lung Cancer Surgery Market Size

The global lung cancer surgery market is projected to grow at a CAGR of 6.8% from 2023 to 2028.

The prevalence of lung cancer surgeries is influenced by several factors, including the global burden of lung cancer and the advancements in surgical techniques. Lung cancer is one of the most prevalent types of cancer worldwide, with a significant impact on public health. The prevalence of lung cancer surgeries is directly correlated with the incidence and prevalence of lung cancer cases. As the number of lung cancer cases continues to rise, the demand for surgical interventions, such as lung resections, lobectomies, and pneumonectomies, also increases.

Furthermore, advancements in surgical techniques have made lung cancer surgeries more accessible and feasible for patients. Minimally invasive approaches, such as VATS and robotic-assisted surgery, have gained popularity due to their benefits, including reduced post-operative pain, shorter hospital stays, and faster recovery. These advancements have expanded the pool of eligible patients for surgical interventions and have contributed to the overall prevalence of lung cancer surgeries.

Overall, the prevalence of lung cancer surgeries is influenced by the burden of lung cancer cases and the availability of advanced surgical techniques, highlighting the significant role that surgical interventions play in the management of lung cancer.

The lung cancer surgery market is driven by several key factors that contribute to its growth and development. Firstly, the rising prevalence of lung cancer worldwide is a major driver, necessitating surgical interventions for diagnosis, staging, and treatment purposes. Secondly, advancements in surgical techniques, such as minimally invasive procedures like video-assisted thoracic surgery (VATS) and robotic-assisted surgery, have improved outcomes and led to reduced post-operative complications. Additionally, the multidisciplinary treatment approach, combining surgery with radiation therapy and chemotherapy, has improved patient outcomes and increased the demand for surgical procedures. The emphasis on early detection and screening programs, the aging population, and the presence of risk factors also drive the demand for lung cancer surgeries. Lastly, supportive reimbursement policies further contribute to the market growth by ensuring better access to surgical interventions. These drivers collectively shape the lung cancer surgery market and highlight the increasing importance of surgical interventions in the management of lung cancer patients.

global lung cancer surgery market

Global Lung Cancer Surgery Market: By Type

The thoracotomy segment is anticipated to witness the largest share in the global lung cancer surgery market during the forecast period. Thoracotomy is a traditional open surgical approach used for lung cancer surgeries. Despite the emergence of minimally invasive techniques like VATS and robotic-assisted surgery, thoracotomy remains a widely adopted procedure due to its long-standing practice, familiarity among surgeons, and the ability to perform complex lung resections. Additionally, thoracotomy allows for optimal visualization and manual dexterity, making it suitable for cases requiring extensive tissue resection or lymph node dissection. These factors contribute to the dominant share of the thoracotomy segment in the lung cancer surgery market.

The minimally invasive surgeries segment is projected to witness the fastest growth in the global lung cancer surgery market during the forecast period. Minimally invasive techniques, such as Video-Assisted Thoracic Surgery (VATS) and robotic-assisted surgery, have gained popularity in recent years due to their advantages over traditional open surgeries. These techniques offer smaller incisions, reduced blood loss, faster recovery, and shorter hospital stays for patients. The demand for minimally invasive surgeries is increasing as they provide comparable oncological outcomes while minimizing patient discomfort and post-operative complications. Factors such as technological advancements, improved surgical instruments, and growing surgeon expertise in these techniques contribute to the rapid growth of the minimally invasive surgeries segment in the lung cancer surgery market.

Global Lung Cancer Surgery Market: By Product

The surgical devices segment is anticipated to hold the largest share in the global lung cancer surgery market during the forecast period. This can be attributed to the increasing adoption of advanced surgical devices specifically designed for lung cancer surgeries. These devices include surgical instruments, staplers, energy devices, endoscopic tools, and imaging systems. The growing prevalence of lung cancer, coupled with the rising demand for minimally invasive procedures, drives the demand for innovative surgical devices. Technological advancements, such as the integration of robotics and advanced imaging techniques, further enhance the precision and effectiveness of lung cancer surgeries. The surgical devices segment is expected to dominate the market due to its crucial role in facilitating successful lung cancer treatment and improving patient outcomes.

The monitoring devices segment is projected to experience rapid growth in the global lung cancer surgery market during the forecast period. This can be attributed to the increasing emphasis on patient monitoring and post-operative care in lung cancer surgeries. Monitoring devices play a vital role in assessing patients' vital signs, oxygen levels, and overall health status during and after surgery. These devices include vital sign monitors, pulse oximeters, cardiac monitors, and respiratory monitoring systems. The growing awareness about the importance of continuous patient monitoring, advancements in monitoring technology, and the rising focus on improving patient outcomes drive the demand for monitoring devices in lung cancer surgery. These devices enable healthcare professionals to closely monitor patients, detect any potential complications, and provide timely interventions, leading to enhanced surgical outcomes and patient safety.

asia pacific lung cancer surgery market

Global Lung Cancer Surgery Market: By Region

The North American region is anticipated to hold the largest share in the global lung cancer surgery market during the forecast period. This can be attributed to several factors. Firstly, North America has a high prevalence of lung cancer, which drives the demand for surgical interventions. Additionally, the region is characterized by well-established healthcare infrastructure, advanced surgical technologies, and a skilled workforce, contributing to the growth of the market. Furthermore, favorable reimbursement policies and government initiatives focused on cancer research and treatment further support the market's expansion in North America. The presence of key market players and ongoing advancements in surgical techniques and equipment also contribute to the region's dominance in the lung cancer surgery market.

Asia-Pacific is projected to experience the fastest growth in the global lung cancer surgery market during the forecast period. Several factors contribute to this growth trend. Firstly, the region has a large population, which increases the overall prevalence of lung cancer and the demand for surgical interventions. Additionally, there is an increasing focus on improving healthcare infrastructure, expanding access to advanced surgical technologies, and enhancing the skills of healthcare professionals in the region. Moreover, rising healthcare expenditures, government initiatives to combat lung cancer, and growing awareness among the population about early detection and treatment options are driving the market's growth in Asia-Pacific.

Global Lung Cancer Surgery Market Share and Competitor Analysis

Accuray Incorporated, GE Healthcare, Johnson & Johnson, Olympus Corporation, Richard Wolf GmbH, Siemens Heathineers, Thermo Fisher Scientific, AngioDynamics, Merck Co., and Medtronic, among others, are some of the key players in the lung cancer surgery market.

Please note: This is not an exhaustive list of companies profiled in the report.

1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS

1.1 Strategic Opportunity & Attractiveness Analysis

1.1.1 Hot Revenue Pockets

1.1.2 Market Attractiveness Score

1.1.3 Revenue Impacting Opportunity

1.1.4 High Growing Region/Country

1.1.5 Competitor Analysis

1.1.6 Consumer Analysis

1.2 Global Market Estimates' View

1.3 Strategic Insights across Business Functions

1.3.1 For Chief Executive Officers

1.3.2 For Chief Marketing Officers

1.3.3 For Chief Strategy Officers

1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into

2 TECHNOLOGICAL TRENDS

2.1 Technological Adoption Rate

2.2 Current Trend Impact Analysis

2.3 Future Trend Impact Analysis

2.4 Data Metrics

3 GLOBAL MARKET OUTLOOK

3.1 Market Pyramid Analysis

3.1.1 Introduction

3.1.2 Adjacent Market Opportunities

3.1.3 Ancillary Market Opportunities

3.2 Demand Side Analysis

3.2.1 Market Drivers: Impact Analysis

3.2.2 Market Restraints: Impact Analysis

3.2.3 Market Opportunities: Impact Analysis

3.2.4 Market Challenges: Impact Analysis

3.3 Supply Side Analysis

3.3.1 Porter’s Five Forces Analysis

3.3.1.1 Threat of New Entrants

3.3.1.2 Threat of New Substitutes

3.3.1.3 Bargaining Power of Suppliers

3.3.1.4 Bargaining Power of Buyers

3.3.1.5 Intensity of Competitive Rivalry

3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)

3.3.2.1 Political Landscape

3.3.2.2 Economic Landscape

3.3.2.3 Social Landscape

3.3.2.4 Technology Landscape

3.3.3 Value Chain Analysis

3.3.4 Trend Analysis

3.3.5 Gap Analysis

3.3.6 Cost Analysis

4 GLOBAL LUNG CANCER SURGERY MARKET, BY TYPE

4.1 Introduction

4.2 Lung Cancer Surgery Market: Type Scope Key Takeaways

4.3 Revenue Growth Analysis, 2022 & 2028

4.4 Thoracotomy

4.4.1 Thoracotomy Market Estimates and Forecast, 2020-2028 (USD Million)

4.5 Minimally Invasive Surgeries

4.5.1 Minimally Invasive Surgeries Market Estimates and Forecast, 2020-2028 (USD Million)

5 GLOBAL LUNG CANCER SURGERY MARKET, BY PRODUCT

5.1 Introduction

5.2 Lung Cancer Surgery Market: Product Scope Key Takeaways

5.3 Revenue Growth Analysis, 2022 & 2028

5.4 Surgical Devices

5.4.1 Surgical Devices Market Estimates and Forecast, 2020-2028 (USD Million)

5.5 Monitoring Devices

5.5.1 Monitoring Devices Market Estimates and Forecast, 2020-2028 (USD Million)

6 GLOBAL LUNG CANCER SURGERY MARKET, BY REGION

6.1 Introduction

6.2 North America Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.2.1 By Type

6.2.2 By Product

6.2.3 By Country

6.2.3.1 U.S. Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.2.3.1.1 By Type

6.2.3.1.2 By Product

6.2.3.2 Canada Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.2.3.2.1 By Type

6.2.3.2.2 By Product

6.2.3.3 Mexico Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.2.3.3.1 By Type

6.2.3.3.2 By Product

6.3 Europe Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.1 By Type

6.3.2 By Product

6.3.3 By Country

6.3.3.1 Germany Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.3.1.1 By Type

6.3.3.1.2 By Product

6.3.3.2 U.K. Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.3.2.1 By Type

6.3.3.2.2 By Product

6.3.3.3 France Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.3.3.1 By Type

6.3.3.3.2 By Product

6.3.3.4 Italy Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.3.4.1 By Type

6.3.3.4.2 By Product

6.3.3.5 Spain Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.3.5.1 By Type

6.3.3.5.2 By Product

6.3.3.6 Netherlands Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.3.6.1 By Type

6.3.3.6.2 By Product

6.3.3.7 Rest of Europe Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.3.3.6.1 By Type

6.3.3.6.2 By Product

6.4 Asia Pacific Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.1 By Type

6.4.2 By Product

6.4.3 By Country

6.4.3.1 China Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.1.1 By Type

6.4.3.1.2 By Product

6.4.3.2 Japan Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.2.1 By Type

6.4.3.2.2 By Product

6.4.3.3 India Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.3.1 By Type

6.4.3.3.2 By Product

6.4.3.4 South Korea Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.4.1 By Type

6.4.3.4.2 By Product

6.4.3.5 Singapore Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.5.1 By Type

6.4.3.5.2 By Product

6.4.3.6 Malaysia Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.6.1 By Type

6.4.3.6.2 By Product

6.4.3.7 Thailand Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.6.1 By Type

6.4.3.6.2 By Product

6.4.3.8 Indonesia Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.7.1 By Type

6.4.3.7.2 By Product

6.4.3.9 Vietnam Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.8.1 By Type

6.4.3.8.2 By Product

6.4.3.10 Taiwan Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.10.1 By Type

6.4.3.10.2 By Product

6.4.3.11 Rest of Asia Pacific Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.4.3.11.1 By Type

6.4.3.11.2 By Product

6.5 Middle East & Africa Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.5.1 By Type

6.5.2 By Product

6.5.3 By Country

6.5.3.1 Saudi Arabia Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.5.3.1.1 By Type

6.5.3.1.2 By Product

6.5.3.2 U.A.E. Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.5.3.2.1 By Type

6.5.3.2.2 By Product

6.5.3.3 Israel Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.5.3.3.1 By Type

6.5.3.3.2 By Product

6.5.3.4 South Africa Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.5.3.4.1 By Type

6.5.3.4.2 By Product

6.5.3.5 Rest of Middle East & Africa Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.5.3.5.1 By Type

6.5.3.5.2 By Product

6.6 Central & South America Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.6.1 By Type

6.6.2 By Product

6.6.3 By Country

6.6.3.1 Brazil Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.6.3.1.1 By Type

6.6.3.1.2 By Product

6.6.3.2 Argentina Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.6.3.2.1 By Type

6.6.3.2.2 By Product

6.6.3.3 Chile Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.6.3.3.1 By Type

6.6.3.3.2 By Product

6.6.3.3 Rest of Central & South America Lung Cancer Surgery Market Estimates and Forecast, 2020-2028 (USD Million)

6.6.3.3.1 By Type

6.6.3.3.2 By Product

7 COMPETITIVE LANDCAPE

7.1 Company Market Share Analysis

7.2 Four Quadrant Positioning Matrix

7.2.1 Market Leaders

7.2.2 Market Visionaries

7.2.3 Market Challengers

7.2.4 Niche Market Players

7.3.4 Rest of the World

7.4 Company Profiles

7.4.1 Accuray Incorporated

7.4.1.1 Business Description & Financial Analysis

7.4.1.2 SWOT Analysis

7.4.1.3 Products & Services Offered

7.4.1.4 Strategic Alliances between Business Partners

7.4.2 GE Healthcare

7.4.2.1 Business Description & Financial Analysis

7.4.2.2 SWOT Analysis

7.4.2.3 Products & Services Offered

7.4.2.4 Strategic Alliances between Business Partners

7.4.3 Johnson & Johnson

7.4.3.1 Business Description & Financial Analysis

7.4.3.2 SWOT Analysis

7.4.3.3 Products & Services Offered

7.4.3.4 Strategic Alliances between Business Partners

7.4.4 Olympus Corporation

7.4.4.1 Business Description & Financial Analysis

7.4.4.2 SWOT Analysis

7.4.4.3 Products & Services Offered

7.4.4.4 Strategic Alliances between Business Partners

7.4.5 Richard Wolf GmbH

7.4.5.1 Business Description & Financial Analysis

7.4.5.2 SWOT Analysis

7.4.5.3 Products & Services Offered

7.4.5.4 Strategic Alliances between Business Partners

7.4.6 Siemens Healthineers

7.4.6.1 Business Description & Financial Analysis

7.4.6.2 SWOT Analysis

7.4.6.3 Products & Services Offered

7.4.6.4 Strategic Alliances between Business Partners

7.4.7 Thermo Fisher Scientific

7.4.7.1 Business Description & Financial Analysis

7.4.7.2 SWOT Analysis

7.4.7.3 Products & Services Offered

7.4.7.4 Strategic Alliances between Business Partners

7.4.8 AngioDynamics

7.4.8.1 Business Description & Financial Analysis

7.4.8.2 SWOT Analysis

7.4.8.3 Products & Services Offered

7.4.8.4 Strategic Alliances between Business Partners

7.4.9 Merck Co.

7.4.9.1 Business Description & Financial Analysis

7.4.9.2 SWOT Analysis

7.4.9.3 Products & Services Offered

7.4.9.4 Strategic Alliances between Business Partners

7.4.10 Medtronic

7.4.10.1 Business Description & Financial Analysis

7.4.10.2 SWOT Analysis

7.4.10.3 Products & Services Offered

7.4.10.4 Strategic Alliances between Business Partners

7.4.11 Other Companies

7.4.11.1 Business Description & Financial Analysis

7.4.11.2 SWOT Analysis

7.4.11.3 Products & Services Offered

7.4.11.4 Strategic Alliances between Business Partners

8 RESEARCH METHODOLOGY

8.1 Market Introduction

8.1.1 Market Definition

8.1.2 Market Scope & Segmentation

8.2 Information Procurement

8.2.1 Secondary Research

8.2.1.1 Purchased Databases

8.2.1.2 GMEs Internal Data Repository

8.2.1.3 Secondary Resources & Third Party Perspectives

8.2.1.4 Company Information Sources

8.2.2 Primary Research

8.2.2.1 Various Type of Respondents for Primary Interviews

8.2.2.2 Number of Interviews Conducted throughout the Research Process

8.2.2.3 Primary Stakeholders

8.2.2.4 Discussion Guide for Primary Participants

8.2.3 Expert Panels

8.2.3.1 Expert Panels Across 30+ Industry

8.2.4 Paid Local Experts

8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region

8.3 Market Estimation

8.3.1 Top-Down Approach

8.3.1.1 Macro-Economic Indicators Considered

8.3.1.2 Micro-Economic Indicators Considered

8.3.2 Bottom Up Approach

8.3.2.1 Company Share Analysis Approach

8.3.2.2 Estimation of Potential Product Sales

8.4 Data Triangulation

8.4.1 Data Collection

8.4.2 Time Series, Cross Sectional & Panel Data Analysis

8.4.3 Cluster Analysis

8.5 Analysis and Output

8.5.1 Inhouse AI Based Real Time Analytics Tool

8.5.2 Output From Desk & Primary Research

8.6 Research Assumptions & Limitations

8.6.1 Research Assumptions

8.6.2 Research Limitations

LIST OF TABLES

1 Global Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

2 Thoracotomy Market, By Region, 2020-2028 (USD Mllion)

3 Minimally Invasive Surgeries Market, By Region, 2020-2028 (USD Mllion)

4 Automotive Market, By Region, 2020-2028 (USD Mllion)

5 Global Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

6 Surgical Devices Market, By Region, 2020-2028 (USD Mllion)

7 Monitoring Devices Market, By Region, 2020-2028 (USD Mllion)

8 Regional Analysis, 2020-2028 (USD Mllion)

9 North America Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

10 North America Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

11 U.S. Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

12 U.S. Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

13 Canada Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

14 Canada Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

15 Mexico Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

16 Mexico Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

17 Europe Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

18 Europe Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

19 Germany Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

20 Germany Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

21 U.K. Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

22 U.K. Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

23 France Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

24 France Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

25 Italy Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

26 Italy Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

27 Spain Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

28 Spain Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

29 Netherlands Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

30 Netherlands Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

31 Rest Of Europe Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

32 Rest Of Europe Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

33 Asia Pacific Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

34 Asia Pacific Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

35 China Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

36 China Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

37 Japan Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

38 Japan Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

39 India Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

40 India Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

41 South Korea Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

42 South Korea Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

43 Singapore Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

44 Singapore Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

45 Thailand Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

46 Thailand Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

47 Malaysia Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

48 Malaysia Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

49 Indonesia Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

50 Indonesia Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

51 Vietnam Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

52 Vietnam Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

53 Taiwan Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

54 Taiwan Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

55 Rest of APAC Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

56 Rest of APAC Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

57 Middle East & Africa Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

58 Middle East & Africa Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

59 Saudi Arabia Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

60 Saudi Arabia Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

61 UAE Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

62 UAE Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

63 Israel Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

64 Israel Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

65 South Africa Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

66 South Africa Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

67 Rest Of Middle East & Africa Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

68 Rest Of Middle East & Africa Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

69 Central & South America Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

70 Central & South America Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

71 Brazil Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

72 Brazil Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

73 Chile Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

74 Chile Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

75 Argentina Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

76 Argentina Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

77 Rest Of Central & South America Lung Cancer Surgery Market, By Type, 2020-2028 (USD Mllion)

78 Rest Of Central & South America Lung Cancer Surgery Market, By Product, 2020-2028 (USD Mllion)

79 Accuray Incorporated: Products & Services Offering

80 GE Healthcare: Products & Services Offering

81 JOHNSON & JOHNSON: Products & Services Offering

82 OLYMPUS CORPORATION: Products & Services Offering

83 Richard Wolf GmbH: Products & Services Offering

84 SIEMENS HEALTHINEERS: Products & Services Offering

85 Thermo Fisher Scientific : Products & Services Offering

86 AngioDynamics: Products & Services Offering

87 Merck Co.: Products & Services Offering

88 Medtronic : Products & Services Offering

89 Other Companies: Products & Services Offering

LIST OF FIGURES

1 Global Lung Cancer Surgery Market Overview

2 Global Lung Cancer Surgery Market Value From 2020-2028 (USD Mllion)

3 Global Lung Cancer Surgery Market Share, By Type (2022)

4 Global Lung Cancer Surgery Market Share, By Product (2022)

5 Global Lung Cancer Surgery Market, By Region (Asia Pacific Market)

6 Technological Trends In Global Lung Cancer Surgery Market

7 Four Quadrant Competitor Positioning Matrix

8 Impact Of Macro & Micro Indicators On The Market

9 Impact Of Key Drivers On The Global Lung Cancer Surgery Market

10 Impact Of Challenges On The Global Lung Cancer Surgery Market

11 Porter’s Five Forces Analysis

12 Global Lung Cancer Surgery Market: By Type Scope Key Takeaways

13 Global Lung Cancer Surgery Market, By Type Segment: Revenue Growth Analysis

14 Thoracotomy Market, By Region, 2020-2028 (USD Mllion)

15 Minimally Invasive Surgeries Market, By Region, 2020-2028 (USD Mllion)

16 Global Lung Cancer Surgery Market: By Product Scope Key Takeaways

17 Global Lung Cancer Surgery Market, By Product Segment: Revenue Growth Analysis

18 Surgical Devices Market, By Region, 2020-2028 (USD Mllion)

19 Monitoring Devices Market, By Region, 2020-2028 (USD Mllion)

20 Regional Segment: Revenue Growth Analysis

21 Global Lung Cancer Surgery Market: Regional Analysis

22 North America Lung Cancer Surgery Market Overview

23 North America Lung Cancer Surgery Market, By Type

24 North America Lung Cancer Surgery Market, By Product

25 North America Lung Cancer Surgery Market, By Country

26 U.S. Lung Cancer Surgery Market, By Type

27 U.S. Lung Cancer Surgery Market, By Product

28 Canada Lung Cancer Surgery Market, By Type

29 Canada Lung Cancer Surgery Market, By Product

30 Mexico Lung Cancer Surgery Market, By Type

31 Mexico Lung Cancer Surgery Market, By Product

32 Four Quadrant Positioning Matrix

33 Company Market Share Analysis

34 Accuray Incorporated: Company Snapshot

35 Accuray Incorporated: SWOT Analysis

36 Accuray Incorporated: Geographic Presence

37 GE Healthcare: Company Snapshot

38 GE Healthcare: SWOT Analysis

39 GE Healthcare: Geographic Presence

40 Johnson & Johnson: Company Snapshot

41 Johnson & Johnson: SWOT Analysis

42 Johnson & Johnson: Geographic Presence

43 Olympus Corporation: Company Snapshot

44 Olympus Corporation: Swot Analysis

45 Olympus Corporation: Geographic Presence

46 Richard Wolf GmbH: Company Snapshot

47 Richard Wolf GmbH: SWOT Analysis

48 Richard Wolf GmbH: Geographic Presence

49 Siemens Healthineers: Company Snapshot

50 Siemens Healthineers: SWOT Analysis

51 Siemens Healthineers: Geographic Presence

52 Thermo Fisher Scientific : Company Snapshot

53 Thermo Fisher Scientific : SWOT Analysis

54 Thermo Fisher Scientific : Geographic Presence

55 AngioDynamics: Company Snapshot

56 AngioDynamics: SWOT Analysis

57 AngioDynamics: Geographic Presence

58 Merck Co.: Company Snapshot

59 Merck Co.: SWOT Analysis

60 Merck Co.: Geographic Presence

61 Medtronic : Company Snapshot

62 Medtronic : SWOT Analysis

63 Medtronic : Geographic Presence

64 Other Companies: Company Snapshot

65 Other Companies: SWOT Analysis

66 Other Companies: Geographic Presence

The Global Lung Cancer Surgery Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Lung Cancer Surgery Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the lung cancer surgery market?

The global lung cancer surgery market is projected to grow at a CAGR of 6.8% from 2023 to 2028.

Who are the major vendors in the lung cancer surgery market?

What are the opportunities prevailing in the lung cancer surgery market?

Opportunities in the global lung cancer surgery market include the development of innovative surgical techniques, increasing focus on precision medicine and personalized treatment approaches, integration of advanced technologies such as robotics and AI in lung cancer surgeries, and the potential for expanded access to healthcare services in emerging markets.

What are the major drivers in the lung cancer surgery market?

The growth of the global lung cancer surgery market is propelled by several factors, including the rising incidence of lung cancer, advancements in surgical techniques and technologies, increased utilization of minimally invasive procedures, a growing elderly population, and supportive government initiatives. These drivers contribute to the increasing demand for lung cancer surgeries, leading to improved patient outcomes and driving overall market expansion.